Gene · 773
NIH grants2,357
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 2,357
Download this page as JSON| Grant | Title | CACNA1A papers | Newest fiscal year |
|---|---|---|---|
| P51OD011133 | The Southwest National Primate Research Center | 1 | 2025 |
| R01AA012404 | Gene Expression in the Human Alcoholic Brain | 1 | 2025 |
| R01AG055357 | Dysregulation of Cav1.2 by beta amyloid peptide | 1 | 2025 |
| R01AG057462 | Endolysosomal defects in secretory autophagy and microglial toxicity in FTD | 1 | 2025 |
| R01AG070864 | Genomic Characterization of Alzheimer Disease Risk in Admixed Populations with Native American and Southern European Genetic Ancestry | 1 | 2025 |
| R01AG071310 | Calcium dysregulation and vulnerability of entorhinal cortex neurons in Alzheimer's disease | 1 | 2025 |
| R01AG072474 | Epidemiological and Genetic Investigations of Blood-Based Biomarkers for Alzheimer's Disease in the Multiethnic, Washington Heights, Inwood, Columbia Aging Project (WHICAP) | 1 | 2025 |
| R01AG072547 | The Origins of Alzheimer Disease in African Americans | 1 | 2025 |
| R01AI093504 | Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning | 1 | 2025 |
| R01AI129269 | Olfactory and neurological manifestations of acute and post-acute murine COVID-19 | 1 | 2025 |
| R01AR075726 | Voltage sensor domain movements in skeletal muscle fiber activation | 1 | 2025 |
| R01CA259396 | The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response | 1 | 2025 |
| R01CA266194 | Selective disruption of histone deacetylase complexes using protein interaction modulators | 1 | 2025 |
| R01CA267872 | STAG2 mutations and 3D genome organization in glioblastoma multiforme | 1 | 2025 |
| R01DA008863 | Regulation Of Opioid Receptor Signaling by Endogenous Peptides | 1 | 2025 |
| R01DA035714 | Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1Tat and cocaine | 1 | 2025 |
| R01DA057866 | Effects of HIV-1 Tat protein and methamphetamine on VMAT2-mediated dopamine transmission in the context of neuroHIV and drug abuse | 1 | 2025 |
| R01DC007664 | Structural Studies of Ion Channel Assembly and Signaling Complexes | 1 | 2025 |
| R01DC019642 | Genetic and epigenomic determinants of hearing loss in Hispanic populations | 1 | 2025 |
| R01DE017102 | TRPC1, Calcium, and Saliva Secretion | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/773/grants?page=9